FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
10/12/2024
Voltar para busca
Dado oficial do USPTO
EVLABIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
EVLABIO
ST13
US500000079351651Classe
5, 9, 35, 36, 42
Pedido
79351651
Registro
7497680
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
36
Atualização mais recente
10/12/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 9, 35, 36, 42
Data de depósito
23/05/2022
Data de registro
10/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
10/09/2024
Última transação
21/11/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH-8038 Zürich, CH
Examinador
THOMAS, JULIE
Unidade examinadora
L70
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
EvlaBio AG
D. K. (pessoa física)
Representantes
Pamela N. Hirschman Davis Graham & Stubbs LLP
Classificação técnica
Classes Nice
Classe 5Classe 9Classe 35Classe 36Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for human usepreparations for the prevention and treatment of cancer and kidney diseases or disorderspreparations for the prevention and treatment of metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorderspreparations for the prevention and treatment of infectious diseasesblood disorderspaininflammationsepsiscognitive disordersdiabetes; biologic preparations for medical and therapeutic purposespreparations for the prevention and treatment of cancer and kidney diseases or disorderspreparations for the prevention and treatment of metabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorderspreparations for the prevention and treatment of infectious diseasesblood disorderspaininflammationsepsiscognitive disordersdiabetes
Classe 9
Data processing equipmentcomputer hardware; downloadable and recorded computer software for providinganalyzing and generating reports in the field of healthcarepharmaceutical and biomedical research; downloadable and recorded computer software for data processing in the field of healthcarepharmaceutical and biomedical research; electronic data processing apparatusdownloadable and recorded softwarecomputer programs and hardware for the scientific analysis and electronic storage of artificial intelligence data in the field of healthcarepharmaceutical and biomedical research; all of the aforementioned goods in the field of healthcarepharmaceutical and biomedical research; downloadable and recorded software for scientific analysis of clinical trial data in the fields of public healthhealthcarepharmaceutical and biomedical research and downloadable and recorded software for scientific analysis of data from clinical trials and data derived from post-authorization research for the marketing of medicines and/or commercial post-launching of medicines; downloadable computer software featuring computer databases of pharmaceuticals and medical information; downloadable computer software for management of medical practices and conducting medical research; downloadable computer software for measuringmonitoringprocessing and tracking health and medical information; downloadable computer search engine software for obtaining and providing updated scientificmedicinalpharmaceutical and clinical information; computer hardware and downloadable and recorded software for use with medicinal patient monitoring equipment and for receivingprocessingtransmitting and displaying data in the field of healthcare; downloadable and recorded artificial intelligence software for tracking data for use in medical and scientific healthcare research
Classe 35
Business data analysis and statistical analysis for business purposes relating to healthcare databiomedical and pharmaceutical research and clinical trial data and data from post-authorization research for marketing of medicines and commercial post-launching of medicines; business analysis and professional business consultancy services regarding statistics for biomedical researchhealthcare institutions and healthcare professionalsbased on artificial intelligence and machine learning; compilation of business dataanalysis of business data and business management analysis in the field of pharmaceutical and biomedical research and developmentclinical trialspost-authorization research for the marketing of medicines and commercial post-launching of medicinesepidemiological researchpharmaco-epidemiological researchpublic health and healthcare; compilation of business dataanalysis of business data and business management analysis for medicalpublic health and healthcare purposes; business researchbusiness market research and statistical analysis of business data in the fields of public healthhealth carebiomedicine and pharmaceuticalsclinical trials and post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing marketing information regarding market intelligence services and competitive intelligence services in the fields of pharmaceuticalsbiomedicineclinical trialspost-authorization research for the marketing of medicines and commercial post-launching of medicinesepidemiological researchpharmaco-epidemiological researchpublic health and healthcare; business risk management and business risk assessment services in the fields of pharmaceuticals and biomedicine; business services provided to the healthcare industrythe collectionbusiness reportinganalysis of healthcare data for business purposes
Classe 36
Financial analysis of investments in pharmaceutical and biomedical research and development and clinical trials and post-authorization research; providing financial services with respect to securities and other financial instruments and productstrading of and investments in securities and financial instruments and products for others; financial evaluationtrackinganalysisforecastingconsultancy and research services relating to securities and other financial instruments; financial research related to financial instruments; clearing and reconciling financial transactions via blockchain technology; electronic funds transfer provided via blockchain technology
Classe 42
Product research in the field of medicalpharmaceutical and biologic therapeutic products; medical researchpharmaceutical research and pharmaceutical drug development services; providing scientific research information in the field of medicalpharmaceuticalsbiomedicineclinical trials and post-authorization research and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software containing databases of pharmaceutical productsmedical informationclinical trial data and data derived from post-authorization research for the marketing of medicines and commercial post-launching of medicines; providing temporary use of online non-downloadable computer software for management of medical practices and conducting medical research; providing temporary use of online non-downloadable computer search engine software for obtaining and providing updated scientificmedical and clinical information; providing temporary use of online non-downloadable computer software for accessing data and information related to healthcare services and patient medicinal information and for controlling and managing data and information related to healthcare services and patient medicinal information; providing temporary use of non-downloadable software applications accessible via a web site for data analyticsfinancial analytics and risk management for use in the fields of pharmaceutical and biomedical research and developmentclinical trialsthe provision of medical and healthcare services; providing temporary use of non-downloadable software for financial analytics via blockchain technology; providing temporary use of non-downloadable artificial intelligence computer programs on data networks for tracking data for use in medical and scientific research; software as a service (SaaS) featuring software platforms for database management in healthcare
Publicações
Histórico de despachos e eventos da marca no USPTO.
36 publicações encontradas
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
17/11/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/11/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/09/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/09/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/08/2024
GPNX
NOTIFICATION PROCESSED BY IB
14/07/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
06/07/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/06/2024
PUBO
PUBLISHED FOR OPPOSITION
18/06/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/06/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
11/06/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/05/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/05/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
13/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/05/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
13/05/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
26/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/03/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/03/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/12/2023
GNFR
FINAL REFUSAL E-MAILED
04/12/2023
CNFR
FINAL REFUSAL WRITTEN
04/12/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/10/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/10/2023
RFNT
REFUSAL PROCESSED BY IB
24/05/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
30/04/2023
RFRR
REFUSAL PROCESSED BY MPU
30/04/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/03/2023
CNRT
NON-FINAL ACTION WRITTEN
11/03/2023
DOCK
ASSIGNED TO EXAMINER
11/03/2023
MAFR
APPLICATION FILING RECEIPT MAILED
11/10/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/10/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/10/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace EVLABIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.